JPWO2023163087A5 - - Google Patents
Info
- Publication number
- JPWO2023163087A5 JPWO2023163087A5 JP2024503247A JP2024503247A JPWO2023163087A5 JP WO2023163087 A5 JPWO2023163087 A5 JP WO2023163087A5 JP 2024503247 A JP2024503247 A JP 2024503247A JP 2024503247 A JP2024503247 A JP 2024503247A JP WO2023163087 A5 JPWO2023163087 A5 JP WO2023163087A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- antibody
- inhibitors
- drugs
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022027751 | 2022-02-25 | ||
| PCT/JP2023/006642 WO2023163087A1 (ja) | 2022-02-25 | 2023-02-24 | 抗変異ｃａｌｒ抗体と他の薬剤とを組み合わせてなる医薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023163087A1 JPWO2023163087A1 (https=) | 2023-08-31 |
| JPWO2023163087A5 true JPWO2023163087A5 (https=) | 2026-02-24 |
Family
ID=87766078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503247A Pending JPWO2023163087A1 (https=) | 2022-02-25 | 2023-02-24 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250161441A1 (https=) |
| EP (1) | EP4483899A1 (https=) |
| JP (1) | JPWO2023163087A1 (https=) |
| KR (1) | KR20240155885A (https=) |
| CN (1) | CN118742324A (https=) |
| AU (1) | AU2023226293A1 (https=) |
| CA (1) | CA3253250A1 (https=) |
| TW (1) | TW202342097A (https=) |
| WO (1) | WO2023163087A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117467004B (zh) * | 2023-10-09 | 2024-06-21 | 武汉爱博泰克生物科技有限公司 | 抗人钙网膜蛋白的兔单克隆抗体及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58201994A (ja) | 1982-05-21 | 1983-11-25 | Hideaki Hagiwara | 抗原特異的ヒト免疫グロブリンの生産方法 |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| WO1993012227A1 (en) | 1991-12-17 | 1993-06-24 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| EP0605522B1 (en) | 1991-09-23 | 1999-06-23 | Medical Research Council | Methods for the production of humanized antibodies |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| CA2131151A1 (en) | 1992-03-24 | 1994-09-30 | Kevin S. Johnson | Methods for producing members of specific binding pairs |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| JPH08509612A (ja) | 1993-04-26 | 1996-10-15 | ジェンファーム インターナショナル インコーポレイテッド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| GB9313509D0 (en) | 1993-06-30 | 1993-08-11 | Medical Res Council | Chemisynthetic libraries |
| WO1995015388A1 (en) | 1993-12-03 | 1995-06-08 | Medical Research Council | Recombinant binding proteins and peptides |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US7112324B1 (en) | 1998-04-21 | 2006-09-26 | Micromet Ag | CD 19×CD3 specific polypeptides and uses thereof |
| JP2008501621A (ja) | 2003-05-31 | 2008-01-24 | マイクロメット アクツィエン ゲゼルシャフト | Ｂ細胞関連疾患を処置するための二重特異性抗ｃｄ３、抗ｃｄ１９抗体構築物を含む薬学的組成物 |
| WO2013026839A1 (en) | 2011-08-23 | 2013-02-28 | Roche Glycart Ag | Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
| US11634502B2 (en) | 2013-03-15 | 2023-04-25 | Amgen Inc. | Heterodimeric bispecific antibodies |
| MX348980B (es) | 2013-09-16 | 2017-07-05 | Cemm-Forschungszentrum Für Molekulare Medizin Gmbh | Calreticulina mutante para la diagnosis de malignidades mieloides. |
| WO2016087514A1 (en) | 2014-12-02 | 2016-06-09 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Anti-mutant calreticulin antibodies and their use in the diagnosis and therapy of myeloid malignancies |
| EP3765517A1 (en) | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| SG11202108494YA (en) | 2019-02-28 | 2021-09-29 | Juntendo Educational Found | Antibodies that bind to cleaved form of mutant calreticulin, and diagnostic, preventive, or therapeutic agent for myeloproliferative neoplasm |
-
2023
- 2023-02-24 TW TW112107062A patent/TW202342097A/zh unknown
- 2023-02-24 EP EP23760086.1A patent/EP4483899A1/en active Pending
- 2023-02-24 AU AU2023226293A patent/AU2023226293A1/en active Pending
- 2023-02-24 KR KR1020247030806A patent/KR20240155885A/ko active Pending
- 2023-02-24 WO PCT/JP2023/006642 patent/WO2023163087A1/ja not_active Ceased
- 2023-02-24 US US18/840,389 patent/US20250161441A1/en active Pending
- 2023-02-24 JP JP2024503247A patent/JPWO2023163087A1/ja active Pending
- 2023-02-24 CA CA3253250A patent/CA3253250A1/en active Pending
- 2023-02-24 CN CN202380023373.8A patent/CN118742324A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022515318A5 (https=) | ||
| JP2021035388A5 (ja) | Ｃａｉｘ、ａｎｏ１、メソテリン、ｔｒｏｐ２またはクローディン−１８．２を標的にする多重特異性結合タンパク質 | |
| JP2021534762A5 (https=) | ||
| JP2010516708A5 (https=) | ||
| JP2022105495A5 (https=) | ||
| JP2022530404A5 (https=) | ||
| JP2018523493A5 (https=) | ||
| JP2022512043A5 (https=) | ||
| JP2021511811A5 (https=) | ||
| JP2020522474A5 (https=) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| JP2024102055A5 (https=) | ||
| JP2014528714A5 (https=) | ||
| JP2024509099A5 (https=) | ||
| JP2013527762A5 (https=) | ||
| RU2009123409A (ru) | Новые антипролиферативные антитела | |
| JP2019513410A5 (https=) | ||
| JP2024538669A5 (https=) | ||
| JP2023550832A5 (https=) | ||
| CN115461373A (zh) | 密蛋白18.2的抗体及其用途 | |
| JPWO2023163087A5 (https=) | ||
| CN115916839A (zh) | 抗pdl1×egfr的双特异性抗体 | |
| JP2024521701A5 (https=) | ||
| JP2023553938A5 (https=) | ||
| JP2019524111A5 (https=) |